These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12841485)

  • 1. The current practice of percutaneous transluminal coronary angioplasty (PTCA) and stent deployment and their long-term results in unstable and stable angina.
    Raju BS; Rao NK
    J Indian Med Assoc; 2003 Feb; 101(2):66-70. PubMed ID: 12841485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with a newer generation coronary stent.
    Manolis AS; Chiladakis J; Hahalis G; Agelopoulos G
    J Invasive Cardiol; 2001 Mar; 13(3):217-22. PubMed ID: 11231647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are directional coronary atherectomy and Palmaz-Schatz stent more efficacious than conventional balloon angioplasty for treating de novo coronary artery lesions?].
    Nanasato M; Adachi M; Hirayama H; Tsuji Y; Yamada T; Yoshida Y; Yamada K; Miwata S; Tsuboi N; Itoh T; Maeda S; Kuriyama K
    J Cardiol; 1997 Sep; 30(3):117-24. PubMed ID: 9309507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of stent implantation versus stent-like angioplasty in unstable angina.
    Marzocchi A; Ortolani P; Piovaccari G; Marrozzini C; Palmerini T; Marinucci L; Saia F; Bacchi-Reggiani ML; Branzi A; Magnani B
    Cardiologia; 1999 Mar; 44(3):261-8. PubMed ID: 10327728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty.
    Wöhrle J; Grebe OC; Nusser T; Al-Khayer E; Schaible S; Kochs M; Hombach V; Höher M
    Circulation; 2003 Apr; 107(14):1840-3. PubMed ID: 12682003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current practice of percutaneous transluminal coronary angioplasty (PTCA) and stent deployment and their long-term results in unstable and stable angina.
    Bhatia V; Bhatia R; Dhindsa S; Virk A
    J Indian Med Assoc; 2004 Oct; 102(10):588, 594. PubMed ID: 15887829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long term course over 10 years after balloon dilatation in stable and unstable angina pectoris].
    Espinola-Klein C; Rupprecht HJ; Trautmann S; Nafe B; Erbel R; Brennecke R; Pop T; Meyer J
    Dtsch Med Wochenschr; 1996 May; 121(18):577-82. PubMed ID: 8625784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of refractory unstable angina by transluminal coronary angioplasty].
    Baladier V; Metzger JP; Le Feuvre C; Georges JL; Vacheron A
    Arch Mal Coeur Vaiss; 1996 Feb; 89(2):181-6. PubMed ID: 8678748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
    N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up results after plain balloon coronary angioplasty.
    Gambhir DS; Sudha R; Singh S; Kaul UA; Arora R
    Indian Heart J; 1999; 51(4):403-9. PubMed ID: 10547938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous transluminal coronary angioplasty in patients over 75 years old with acute myocardial infarct or unstable angina pectoris].
    Wojcik J; Chemnitius JM; Scholz KH; Ashmawy M; Kreuzer H; Tebbe U
    Med Klin (Munich); 1990 Jul; 85(7):409-14. PubMed ID: 2385205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis.
    Moustapha A; Assali AR; Sdringola S; Yusuf SW; Vaughn WK; Fish RD; Schroth GW; Krajcer Z; Rosales OR; Smalling RW; Anderson HV
    Catheter Cardiovasc Interv; 2002 Jun; 56(2):184-7. PubMed ID: 12112910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced incidence of clinical restenosis with newer generation stents, stent oversizing, and high-pressure deployment: single-operator experience.
    Manolis AS
    Clin Cardiol; 2001 Feb; 24(2):119-26. PubMed ID: 11214741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention.
    Huang R; Sacks J; Thai H; Goldman S; Morrison DA; Barbiere C; Ohm J
    Catheter Cardiovasc Interv; 2005 May; 65(1):25-33. PubMed ID: 15800889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
    Mehilli J; Kastrati A; Schühlen H; Dibra A; Dotzer F; von Beckerath N; Bollwein H; Pache J; Dirschinger J; Berger PP; Schömig A;
    Circulation; 2004 Dec; 110(24):3627-35. PubMed ID: 15531766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era.
    Adelman AG; Caramori PR; Cohen EA; Chisholm RJ; Côté G; Ducas J; O'Neill BJ; Tcheng JE
    Can J Cardiol; 1998 Aug; 14(8):1057-66. PubMed ID: 9738165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.